Want to track NGNE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurogene Inc. (NGNE) Statistics
Valuation metrics
Market Cap 617.55M
Enterprise value 474.55M
Trailing P/E (ttm) -7.42
Forward P/E -
PEG ratio 0.91
Price/Sales (ttm) -
Price/Book (mrq) 3.5
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 472.37K
Average volume (90 days) 182.15K
Price summary
52-Week low 15.93
52-Week high 43.66
Beta -
50-Day moving average 31.17
200-Day moving average 22.63
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 19 Dec 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.37%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.42
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.9
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 13.08%
Book value per share (mrq) 10.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
